Insider · CIK 0001550545
John S Yu
Files at KAPA (Kairos Pharma, LTD.). First filing Nov 21, 2024, latest Nov 21, 2024.
John S Yu files SEC Form 4 as CEO, chair, director and 10% owner at KAPA (Kairos Pharma, LTD.). Since Nov 21, 2024, John S Yu has reported 1 open-market buy worth $5,760 and 0 open-market sells worth $0, the latest filed on Nov 21, 2024.
A track record needs three past buys with six months of prices behind them; John S Yu has 0, so none is measured yet.
The newest scored trade: bought $5,760 of KAPA on Nov 20, 2024, filed Nov 21, 2024, scored 35 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KAPA: Kairos Pharma, LTD.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | KAPA Kairos Pharma, LTD. | AGrant or award COMMON STOCK | +190,840 | $0.00 | $0 | 230,105 | Nov 26, 2025 |
| Jan 1, 2025 | KAPA Kairos Pharma, LTD. | AGrant or award COMMON STOCK | +14,000 | $0.00 | $0 | 5,355,838 | Feb 24, 2025 |
| Nov 20, 2024 | KAPA Kairos Pharma, LTD. | POpen-market purchase COMMON STOCK | +4,000 | $1.44 | $5,760 | 5,341,837 | Nov 21, 2024 |
Questions about John S Yu
Answered from the filings on this page, as of the latest one.
Is John S Yu buying or selling?
Not in the last 12 months. John S Yu's latest open-market trade on SEC Form 4 was bought $5,760 of KAPA on Nov 20, 2024.
How did John S Yu's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John S Yu has 0.
Where does John S Yu file Form 4?
John S Yu has filed Form 4 at KAPA (Kairos Pharma, LTD.) as CEO and Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.